RAO, Angela
 Distribuzione geografica
Continente #
NA - Nord America 494
EU - Europa 376
AS - Asia 79
Continente sconosciuto - Info sul continente non disponibili 1
Totale 950
Nazione #
US - Stati Uniti d'America 490
IE - Irlanda 118
SE - Svezia 80
UA - Ucraina 73
CN - Cina 72
DE - Germania 38
GB - Regno Unito 32
FI - Finlandia 19
RU - Federazione Russa 5
IN - India 4
BE - Belgio 3
CA - Canada 3
FR - Francia 2
IR - Iran 2
AT - Austria 1
DK - Danimarca 1
EU - Europa 1
HR - Croazia 1
NL - Olanda 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 950
Città #
Jacksonville 121
Dublin 118
Chandler 97
Nyköping 68
Ashburn 34
Beijing 30
Dearborn 28
Cambridge 18
Medford 18
Princeton 18
Des Moines 15
Boardman 14
Ann Arbor 12
Lancaster 10
Nanjing 6
Hebei 5
Jinan 4
San Mateo 4
Shenyang 4
Zhengzhou 4
Brussels 3
Edinburgh 3
Frankfurt am Main 3
Haikou 3
Ottawa 3
Taizhou 3
Wilmington 3
Ardabil 2
Bangalore 2
Leawood 2
Los Angeles 2
Taiyuan 2
Tianjin 2
Woodbridge 2
Augusta 1
Bucharest 1
Changsha 1
Copenhagen 1
Cormeilles-en-Parisis 1
Hangzhou 1
Hanover 1
Helsinki 1
Kemerovo 1
Kyiv 1
Lisbon 1
Manchester 1
Mumbai 1
Nanchang 1
New York 1
Ningbo 1
Norwalk 1
Novokuznetsk 1
Panama City 1
Paris 1
Pune 1
Riva 1
Saint Louis 1
Saint Petersburg 1
Stockholm 1
Vienna 1
Washington 1
Xiangfen 1
Zagreb 1
Ürümqi 1
Totale 693
Nome #
Microwave-assisted synthesis of benzimidazole and thiazolidinone derivatives as HIV-1 RT inhibitors 72
Anti-HIV agents: design and discovery of new potent RT inhibitors 66
2-(2,6-dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors 63
Synthesis and metabolic study of 1H,3H-oxazolo[3,4-a]benzimidazoles, a new class of non-nucleoside HIV-1 RT-inhibitors. 61
Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs) 60
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 58
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones 57
Efficient 3D Database screening for novel HIV-1 IN inhibitors 56
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin- 4-(thi)one derivatives 54
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents 53
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti- HIV-1 agents 53
Synthesis of new 2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents 53
Synthesis and structural features of new cyclofunctionalized benzimidazoles 49
Synthesis and antitumour activity of 1H,3H-thiazolo[3,4- a]benzimidazole derivatives 48
7-Chloro-1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazole and 1-(2,6-difluorophenyl)-6-methyl-1H,3H- thiazolo[3,4-a]benzimidazole 45
Synthesis of new potential HIV-1 integrase inhibitors 42
Synthesis and biological activity of novel 1H,3H-thiazolo[3,4- a] benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors 40
Synthesis and anti-HIV activity of 1-(2,6-difluorophenyl)- 1H,3H-thiazolo[3,4-a]benzimidazole structurally-related 1,2- substituted benzimidazoles 37
Totale 967
Categoria #
all - tutte 3.486
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.486


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 0 1
2019/2020191 39 17 0 17 0 27 22 21 2 28 18 0
2020/2021111 18 0 24 1 1 17 0 17 0 18 14 1
2021/2022120 5 35 2 3 8 0 11 3 0 1 15 37
2022/2023391 23 32 27 23 32 42 5 35 149 2 20 1
2023/202463 5 13 2 22 5 13 1 0 0 2 0 0
Totale 967